Bone densitometry manufacturer Norland Medical Systems turned in financial results for the first quarter (end-March) that showed none of the problems that have been dogging other bone-mass measurement companies in recent weeks. For the period,
Bone densitometry manufacturer Norland Medical Systems turned in financial results for the first quarter (end-March) that showed none of the problems that have been dogging other bone-mass measurement companies in recent weeks. For the period, Norland had sales of $4.8 million, up 134% compared with $2.1 million in the first quarter of 1998. The firms net loss shrank to $615,000, compared with a net loss of $1.9 million in the same period the year before. Norland executives said the companys numbers should improve even further as it begins recognizing revenue from its new Excell dual-energy x-ray absorptiometry axial scanner, which began shipping in March.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.